Items where authors include "Roylance, R."

Article

Khan, I. orcid.org/0000-0002-2069-7410, Taylor, S.J.C., Robinson, C. et al. (15 more authors) (2024) Study protocol for a pragmatic randomised controlled trial of comparing enhanced acceptance and commitment therapy plus (+) added to usual aftercare versus usual aftercare only, in patients living with or beyond cancer: SUrvivors’ Rehabilitation Evaluation after CANcer (SURECAN) trial. Trials, 25 (1). 228. ISSN 1745-6215

Ring, A. orcid.org/0000-0003-1230-2973, Kilburn, L.S. orcid.org/0000-0002-1987-7545, Pearson, A. orcid.org/0000-0002-5854-193X et al. (21 more authors) (2023) Olaparib and ceralasertib (AZD6738) in patients with triple-negative advanced breast cancer: Results from Cohort E of the plasmaMATCH trial (CRUK/15/010). Clinical Cancer Research, 29 (23). pp. 4751-4759. ISSN 1078-0432

Starkey, T., Ionescu, M.C., Tilby, M. et al. (64 more authors) (2023) A population-scale temporal case–control evaluation of COVID-19 disease phenotype and related outcome rates in patients with cancer in England (UKCCP). Scientific Reports, 13. 11327. ISSN 2045-2322

Escala-Garcia, M., Guo, Q., Dörk, T. et al. (234 more authors) (2019) Genome-wide association study of germline variants and breast cancer-specific mortality. British Journal of Cancer, 120. pp. 647-657. ISSN 0007-0920

Tutt, A., Tovey, H., Cheang, M.C.U. et al. (35 more authors) (2018) Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial. Nature Medicine, 24 (5). pp. 628-637. ISSN 1078-8956

Petridis, C., Brook, M.N., Shah, V. et al. (92 more authors) (2016) Genetic predisposition to ductal carcinoma in situ of the breast. Breast Cancer Research, 18 (1). 22. ISSN 1465-542X

Sawyer, E., Roylance, R., Petridis, C. et al. (151 more authors) (2014) Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast. PLoS Genetics, 10 (4). e1004285. ISSN 1553-7390